Kelly K Hunt

Professor of Surgery at MD Anderson Cancer Center. Devoted to cancer care & research. Tweets are my own.

[Annals of Surgical Oncology @AnnSurgOncol]

March Issue: Development of a Reproducible Framework and Pathway to Support Innovation in an Academic #SurgicalDepartment @KellyKhunt

https://t.co/NP05Rp8EiX

@SyedAAhmad5
@SocSurgOnc

[Society of Surgical Oncology @SocSurgOnc]

Did you hear? Registration is now open for the #SSO2026 Annual Meeting! 🎉

Join us March 5–7, 2026 in Phoenix, Arizona, for cutting-edge education, networking, and more.

Don’t wait—secure your spot today! https://t.co/rLNFBbqYIU

[Society of Surgical Oncology @SocSurgOnc]

New episode!

Dr. Olga Kantor, Brigham and Women’s Hospital, and Dr. Taiwo Adesoye, MD Anderson Cancer Center, dive into key breast track highlights from #SSO2025 — including practice-changing trials you won’t want to miss.

Listen now: https://t.co/aQE7402pMi

[Helen M. Johnson, MD, IBCLC @HelenMJohnsonMD]

Strong presentation by @MDAndersonNews BSO fellow Dr Tori Hunyh @THuynhMD at #ASBrS2025 @ASBrS. #pCR is associated with superior oncologic outcomes. In the setting of residual disease, LRR after BCT differs by subtype. @KellyKhunt @crgcrsn @HenryKuerer @puneetsinghmd

[Society of Surgical Oncology @SocSurgOnc]

The Society of Surgical Oncology is pleased to announce the newly installed Officers and Board Members as they officially begin their term for the 2025-2026 governance year. Please join us in welcoming them! https://t.co/8nmiekbb1G

[Helen M. Johnson, MD, IBCLC @HelenMJohnsonMD]

Congratulations to Drs Tori Hunyh and Ashley Cairns, @MDAndersonNews breast surgical oncology fellows, on their #SSO2025 podium presentations! @SocSurgOnc @HenryKuerer @KellyKhunt @puneetsinghmd @crgcrsn

[Jennifer Plichta MD (she/her) @JenniferPlichta]

So thankful 🙏 to have been a member of the inaugural @SocSurgOnc Career Catalyst Program and for my amazing mentor @KellyKhunt !!

[Sanjay S. Reddy @SanjaySReddy]

Recently completed our year long @SocSurgOnc #careercatalyst program with 7 amazing mentees! Special 🙏 to my mentors @DarrenCarpizo and Dr. David Linehan, and #SSO leadership @KellyKhunt and @hpbshoup! @URochester_SMD @URochesterSurg @WilmotCancer @FoxChaseCancer @TempleHealth

[OncoDaily @oncodaily]

Targeting the Cell Cycle Machinery in Cancer with @kandymarsy and @KellyKhunt - @weldeiry

https://t.co/3DiCvx16Ct

#FightAgainstCancer #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

[Khandan Keyomarsi @kandymarsy]

We are pleased to share our latest findings on the molecular mechanisms driving resistance to CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer, published in Molecular Cancer https://t.co/IiB82qcNzC (Luo et al., 2025, DOI: 10.1186/s12943-025-02226-9)!

[Kelly K Hunt @KellyKhunt]

Don’t forget to watch the video with Dr. Mamounas! He has so much experience to share! #BRCAbrief @DrSGraff @SocSurgOnc @ASBrS

[Integrity CE SoMe CME @SoMeCME]

Catch this #BRCABrief tonight on @SoMeCME!

🗣️ Terry Mamounas, MD, MHP, FACS, @DrSGraff, & @KellyKhunt will cover what the future holds in BRCA+ early #breastcancer

🗓️ Wednesday, February 12, 2025
🕔 5:00 PM EST

Follow along using #BRCABrief

[Kelly K Hunt @KellyKhunt]

Thanks @DrSGraff #BRCA testing can have implications for individual patient treatment plans and potential for cascade testing to their family members. #BRCAbrief

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

@SoMeCME @KellyKhunt Learn more about methods to meet patient needs in #BRCA testing and counseling #BRCAbrief
👉 https://t.co/f1P2zQy22w

[Kelly K Hunt @KellyKhunt]

Know the guidelines. Surgeons and APPs need to be all in for our patients! Surgeons can definitely help with offering germline testing #BRCAbrief https://t.co/TEK9hG7wc2
@SocSurgOnc @ASBrS @DrSGraff

[Integrity CE SoMe CME @SoMeCME]

2/ Guidelines support expanded germline testing, but most genetic counselors are distributed across only 10 states

What are the available options❓

👉 https://t.co/65GUTk4iXu

#BRCABrief #BCRA

[Kelly K Hunt @KellyKhunt]

Check out this educational opportunity to learn more about BRCA+ early breast cancer with Dr. Terry Mamounas @DrSGraff @SocSurgOnc @ASBrS

[Integrity CE SoMe CME @SoMeCME]

Catch this #BRCABrief tonight on @SoMeCME!

🗣️ Terry Mamounas, MD, MHP, FACS, @DrSGraff, & @KellyKhunt will cover what the future holds in BRCA+ early #breastcancer

🗓️ Wednesday, February 12, 2025
🕔 5:00 PM EST

Follow along using #BRCABrief

[Society of Surgical Oncology @SocSurgOnc]

Happy #InternationalDayofWomenandGirlsinScience! Today, we celebrate the incredible women shaping the future of surgical oncology through research, innovation, and leadership. SSO is proud to support and uplift women in science! #SSOCommunity

[Kelly K Hunt @KellyKhunt]

Don’t forget to watch the video w/Dr. Terry Mamounas on how germline testing impacts treatment @DrSGraff #BRCAbrief

[Integrity CE SoMe CME @SoMeCME]

6/ We hope you enjoyed this #BRCAbrief!

Complete the posttest & evaluation here 👉 https://t.co/t6EELvuAJv
& claim your 🆓 CME!

🗓️ See you for our next #breastcancer #BRCA brief w/ Terry Mamounas, MD, @DrSGraff, & @KellyKhunt

[Kelly K Hunt @KellyKhunt]

Learn more about integrating olaparib in the management of patients with germline BRCA mutations who have early breast cancer https://t.co/TIwKv78dMm

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

@SoMeCME Adjuvant olaparib significantly improves IDFS, DDFS, and OS in #BRCAbrief @KellyKhunt

Here’s the abstract from #SABCS24 @judygarber5 👉 https://t.co/UoPN700SP5

[Kelly K Hunt @KellyKhunt]

Agree @DrSGraff and patients with germline #BRCA mutations who have residual disease following neoadjuvant systemic therapy should be considered for adjuvant therapy with a PARP inhibitor. #BRCAbrief

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

@SoMeCME @KellyKhunt And importantly, how do you capture all the patients that qualify for testing? Any patient who may be eligible for a PARP inhibitor is eligible for testing—which includes ER+ disease. #BRCAbrief

[Kelly K Hunt @KellyKhunt]

Let’s start the conversation. It takes the whole multidisciplinary team to develop the optimal treatment program for our patients @DrSGraff Dr. Terry Mamounas @SocSurgOnc @ASBrS #BRCAbrief #bcsm

[Integrity CE SoMe CME @SoMeCME]

1/ #BRCAbrief #BRCA

Personalizing treatment decisions in early #breastcancer w/ Terry Mamounas, MD, @DrSGraff, & @KellyKhunt

Supported by educational grants from AstraZeneca Pharmaceuticals and Merck Sharp & Dohme LLC.

CME ℹ️ https://t.co/6uwlzSxbWb

📊 What is your specialty/degree❓

[Society of Surgical Oncology @SocSurgOnc]

From the February Issue of @AnnSurgOncol: Significance of Residual Nodal Disease in Clinically Node-Negative #BreastCancer After #NeoadjuvantChemotherapy
@KellyKhunt
@HenryKuerer
@AbigailCaudleMD
https://t.co/jNxZna94bz
@shadyx2520

@SyedAAhmad5